Fidelis Capital Partners, LLC Astrazeneca PLC Transaction History
Fidelis Capital Partners, LLC
- $840 Billion
- Q3 2024
A detailed history of Fidelis Capital Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Fidelis Capital Partners, LLC holds 17,491 shares of AZN stock, worth $1.16 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
17,491
Previous 16,013
9.23%
Holding current value
$1.16 Million
Previous $1.29 Billion
4.26%
% of portfolio
0.16%
Previous 0.18%
Shares
8 transactions
Others Institutions Holding AZN
# of Institutions
1,360Shares Held
476MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.18 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.79 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.47 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.44 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.3MShares$1.28 Billion0.43% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $206B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...